Thesis (Selection of subject)Thesis (Selection of subject)(version: 368)
Thesis details
   Login via CAS
Vyhodnotenie aktivity potencionálne antibakteriálnych látok pomocou mikrodilučnej bujónovej metódy
Thesis title in thesis language (Slovak): Vyhodnotenie aktivity potencionálne antibakteriálnych látok pomocou mikrodilučnej bujónovej metódy
Thesis title in Czech: Vyhodnocení aktivity potenciálně antibakteriálních látek pomocí mikrodiluční bujónové metody
Thesis title in English: Evaluation of activity of potentional antibacterial substances through the use of microdilution broth method
Key words: bakterie, antibiotika, minimální inhibiční koncentrace
English key words: bacteria, antibiotics, minimal, inhibitory concentrations
Academic year of topic announcement: 2015/2016
Thesis type: diploma thesis
Thesis language: slovenština
Department: Department of Biological and Medical Sciences (16-16150)
Supervisor: Mgr. Marcela Vejsová, Ph.D.
Author: hidden - assigned by the advisor
Date of registration: 13.11.2015
Date of assignment: 09.05.2017
Date and time of defence: 29.05.2017 08:00
Date of electronic submission:10.05.2017
Date of proceeded defence: 29.05.2017
Opponents: PharmDr. Ondřej Janďourek, Ph.D.
 
 
 
Guidelines
1. Rešerše literatury
2. Zvládnutí základních mikrobiologických laboratorních technik
3. Vypracování postupu vyhodnocení antibakterální aktivity in vitro pomocí mikrodiluční bujónové metody
4. Vlastní experimenty
5. Zpracování výsledků
6. Vyhodnocení výsledků, jejich interpretace a diskuze s využitím teoretických a praktických znalostí dané problematiky
References
Votava M. et al: Lékařská mikrobiologie speciální, Neptun, Brno 2003.
Votava M. et al: Lékařská mikrobiologie II., Přehled vyšetřovacích metod v lékařské mikrobiologii, Masarykova univerzita, Brno 2000
Scharfen J. (2013) Diferenciální diagnostika v klinické mikrobiologii. Nucleus HK, Praha, 236 s. ISBN 978-80-87009-32-1
Greenwood D., Slack R. C. B., Peutherer J. F. a kol. (1999) Lékařská mikrobiologie. Grada, Praha, 686 s. ISBN 80-7169-365-0
Mahon R. C., Manuselis G. (2000) Textbook of Diagnostic Microbiology. W. B. Sauders Company, Philadelphia, 2. vydání, 1230 s. ISBN 0-7216-7917-X
Mangoni ML, Luca V, McDermott AM. Fighting microbial infections: A lesson from amphibian skin-derived esculentin-1 peptides. Peptides. 2015 Sep;71:286-95.
Véronique Dartois, Jorge Sanchez-Quesada, Edelmira Cabezas, Ellen Chi, Chad Dubbelde, Carrie Dunn, Juan Granja, Colleen Gritzen, Dana Weinberger, M. Reza Ghadiri, and Thomas R. Parr, Jr. Systemic Antibacterial Activity of Novel Synthetic Cyclic Peptides. Antimicrob Agents Chemother. 2005 August; 49(8): 3302–3310.
John Turnidge and David L. Paterson. Setting and Revising Antibacterial Susceptibility Breakpoints. Clin Microbiol Rev. 2007 July; 20(3): 391–408.
Lin SY, Huang CH, Ko WC, Chen YH, Hsueh PR. Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections. Expert Opin Pharmacother. 2015 Nov 19.
Wong JP, DiTullio P, Parkinson S. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria. Future Microbiol. 2015 Nov;10:1751-8.
Lin SY, Huang CH, Ko WC, Chen YH, Hsueh PR. Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections. Expert Opin Pharmacother. 2015 Nov 19.
Wu MT, Burnham CD, Westblade LF, Dien Bard J, Lawhon SD, Wallace MA, Stanley T, Burd E, Hindler J, Humphries RM. Evaluation of oxacillin and cefoxitin disk and MIC breakpoints for the prediction of methicillin resistance in human and veterinary isolates of Staphylococcus intermedius group. J Clin Microbiol. 2015 Nov 25.
Wattal C, Oberoi JK. Microbial identification and automated antibiotic susceptibility testing directly from positive blood cultures using MALDI-TOF MS and VITEK 2. Eur J Clin Microbiol Infect Dis. 2015 Nov 19.
Toner L, Papa N, Aliyu SH, Dev H, Lawrentschuk N, Al-Hayek S. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years. World J Urol. 2015 Oct 28.
Hombach M, Ochoa C, Maurer FP, Pfiffner T, Böttger EC, Furrer R. Relative contribution of biological variation and technical variables to zone diameter variations of disc diffusion susceptibility testing. J Antimicrob Chemother. 2015 Oct 12.
Krasauskas R, Labeikytė D, Markuckas A, Povilonis J, Armalytė J, Plančiūnienė R, Kavaliauskas P, Sužiedėlienė E. Purification and characterization of a new β-lactamase OXA-205 from Pseudomonas aeruginosa. Ann Clin Microbiol Antimicrob. 2015 Nov 26;14(1):52.
Marques CN, Davies DG, Sauer K. Control of Biofilms with the Fatty Acid Signaling Molecule cis-2-Decenoic Acid. Pharmaceuticals (Basel). 2015 Nov 25;8(4):816-835. Review.
Qiu XQ, Roy SM, Riley MA. Pheromonicins: an ecologically sound family of bacteriocin-based antibiotics for use in the age of the microbiome. Future Microbiol. 2015 Dec;10:1969-79.
Grau-Campistany A, Manresa Á, Pujol M, Rabanal F, Cajal Y. Tryptophan-containing lipopeptide antibiotics derived from polymyxin B with activity against Gram positive and Gram negative bacteria. Biochim Biophys Acta. 2015 Nov 22. pii: S0005-2736(15)00383-1.
http://www.szu.cz/metody-nrl-pro-antibiotika
 
Charles University | Information system of Charles University | http://www.cuni.cz/UKEN-329.html